A

Aethon Therapeutics

2 employees

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Product Research
drug development
immuno-oncology
cancer drugs
biomedical research

Date founded

2022

Funding rounds raised

Total raised

$30M

from 2 investors over 2 rounds

A

Aethon Therapeutics raised $30M on January 9, 2023

Investors: NYU Medical Center and ATP (Apple Tree Partners)

FAQ